New therapeutic perspectives for brain injury and disease
Seminar given by Prof. Nancy Rothwell, School of Biological Sciences, The University of Manchester and Prof. Alain Buisson, Institute of Applied Biology and Biochemistry, University of Caen, France
Royal Society of Medicine, 29 June 2006 at 6pm
(Due to the lecturers’ strike, Prof. Nancy Rothwell has been requested to stay at the University of Manchester to supervise all exam markings and will be replaced by Dr. Stuart Allan)
Alzheimer’s & Parkinson’s diseases... Epilepsy... Stroke...
The common denominator for these disorders is inflammation. We know it, yet we have no cures or effective treatments. Still, new approaches are being experimentally tested and research advances are encouraging. Scientists are investigating two molecules (IL-1 and Glutamate) that cause inflammation and are responsible, at least in part, for these disorders.
Come and discover how selective blocking of Glutamate receptors and reduction of brain injury caused by IL-1 might present a therapeutic interest in not-too-far a future.
Where? Royal Society of Medicine
1 Wimpole Street
London
W1G 0AE
When? Thursday 29th June at 6pm
Drink reception will follow
Register free at event ambascience.co.uk